In summary, our findings demonstrated a significant correlation among PLOD gene expression, tumor prognosis, and cancer immune microenvironment, indicating that PLOD family members may mediate tumor progression and exert immunotherapeutic effects on HCC. This evidence concerns the gene PLOD1 and neoplasm.